Navigation Links
First Southeast Venture Philanthropy Summit Set In NC
Date:3/13/2013

RESEARCH TRIANGLE PARK, N.C., March 13, 2013 /PRNewswire-USNewswire/ -- The first Southeast Venture Philanthropy Summit will bring some 200 leaders of regional life science companies and national disease foundations to Chapel Hill April 3 and 4 to explore alliances bearing new opportunities.

The Summit will connect company leaders, academic researchers, funding specialists and executives from 30 foundations and philanthropic groups targeting a wide range of diseases and conditions.

The Summit has been organized by the North Carolina Biotechnology Center in conjunction with BioFlorida, Georgia Bio , NCBIO, Southeast BIO and Virginia Bio . They were aided by a steering committee including members of those organizations plus leaders from the venture philanthropy, venture capital and academic communities.

"Foundation funding, or venture philanthropy, has increased in terms of the breadth of funding options available and the size of the grants and investments these organizations are making," said Peter Ginsberg , vice president of Business and Technology Development at NCBiotech. "However, few life science companies or academic institutions in the Southeast have benefited from venture philanthropy."

Many companies throughout the Southeast are working to commercialize discoveries from academic and corporate labs that could help disease foundations in their struggle to advance new therapies -- and possibly even cures.

Ginsberg was encouraged to organize this regional Summit after 170 participants crowded into an NCBiotech forum he led that featured four venture philanthropy executives.

This Summit will build on that interest with a full-day conference preceded by a reception the evening before, both in Chapel Hill. Discounted advance registration runs through April 1, space permitting.

Foundation funding benefits extend well beyond the dollars involved, said Ginsberg. "Besides money, recipients also receive access to thought leaders, partners and patients, as well as a 'stamp of approval' from a well-recognized body of experts."

Many life science entrepreneurs and academic scientists in the Southeast are unaware of this growing funding opportunity, he added. And others are not familiar with the best ways to attract foundation funding. The Summit is also designed to address those gaps.  

NCBiotech is a private, non-profit corporation supported by the N.C. General Assembly. Its mission is to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business, education and strategic policy statewide.


'/>"/>
SOURCE NCBiotech
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
2. Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
3. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
4. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
5. Webcor Builders Selected as the General Contractor for First Phase of LA BioMeds New Campus Master Plan
6. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2012 Financial Results
7. Tiger Woods Gives Exclusive First Interview Since POWERED by FUSE Announcement!
8. The Pharmabiotic Research Institute (PRI) is Preparing to Publish its First Works on the Therapeutic and Medicinal Potential of Probiotics
9. Eye Surgery Center of Michigan First in Southeast Michigan to Perform Bladeless Cataract Surgery Using New LenSx® Laser Technology
10. Amgen Announces 2012 First Quarter Dividend
11. Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... UTAH. (PRWEB) , ... May 25, 2016 , ... WEDI, ... healthcare information exchange, today announced that Charles W. Stellar has been named by the ... interim CEO since January 2016. As an executive leader with more than 35 years ...
(Date:5/24/2016)... La Jolla, CA (PRWEB) , ... May 24, 2016 , ... ... and financial planning for corporate executives and entrepreneurs, held The Future of San Diego ... leaders in the San Diego life science community attended the event with speakers Dr. ...
(Date:5/23/2016)... England , May 23, 2016 ... May 25 th at 10:15 a.m. ET before the ... the role genetically engineered mosquitos can play in controlling the ... carrier of the Zika virus.      (Logo: ... engineered male mosquito with a self-limiting gene. Trials in ...
(Date:5/20/2016)... ... May 20, 2016 , ... The leading Regenerative Veterinary ... most experienced veterinary clients have treated over 100 of their own patients with the ... provide the highest level of care for their patients. , The veterinarians are ...
Breaking Biology Technology:
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
(Date:3/21/2016)... -- Unique technology combines v ...   Xura, Inc. (NASDAQ: ... communications services, today announced it is working alongside SpeechPro ... particularly those in the Financial Services Sector, the ability ... a mobile app, alongside, and in combination with, traditional ...
(Date:3/14/2016)... NXTD ) ("NXT-ID" or the "Company"), ... the airing of a new series of commercials on Time ... 21 st .  The commercials will air on Bloomberg TV, ... the Street show. --> NXTD ) ("NXT-ID" or ... market, announces the airing of a new series of commercials ...
Breaking Biology News(10 mins):